Browse diseases

…Colorectal cancer (CRC) remains a major global health burden, and despite advance…

…erage risk of CRC will be included. The primary outcome will be colorectal neoplasia risk, while behavioural change, mortality and QoL will be consi…

…on of activated CD8+ T cells in the tumor. Blocking CCL7 delays CRC progression and enhances the therapeutic efficacy of PD-L1.Conc…

…B = –0.175, p=0.045; n=152).Conclusions Unprompted awareness of CRC symptoms and risk factors was suboptimal in this population, wi…

…Background Colorectal cancer (CRC) is the third most prevalent cancer globally. 1 Approximat…

…f b-catenin/BCL9 with ST316 as a novel therapeutic approach for CRC.Ethics Approval All aspects of animal care were in accordance w…

…A 57-year-old male was diagnosed with moderately differentiated CRC (pT3pN1(3/12)-M0, stage IIIB) and underwent left hemicolectomy …

…r decades into a frontline treatment for multiple malignancies. Colorectal cancer (CRC), an early-onset and high-mortality cancer type, demonstra…

…(Nivo) is an anti-PD-1 immune checkpoint inhibitor approved for colorectal cancer (CRC), yet responses are highly variable between patients, and …

… FOXP3+CD25+CD127– Treg cells in colorectal cancer.KRAS-mutated colorectal cancer (CRC) tumors exhibited significantly higher frequencies of both…

…s CGRP and RAMP1 expression in primary colorectal cancer (CRC), CRC liver metastases and gastric cancers (GC). RAMP1 expression was…

…Objective Colorectal cancer (CRC) screening is critical for early detection and prevention.…